PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-59.37%
Negative revenue growth while OBE stands at 76.01%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-86.14%
Negative gross profit growth while OBE is at 99.45%. Joel Greenblatt would examine cost competitiveness or demand decline.
-763.74%
Negative EBIT growth while OBE is at 182.31%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-763.74%
Negative operating income growth while OBE is at 586.21%. Joel Greenblatt would press for urgent turnaround measures.
-12450.00%
Negative net income growth while OBE stands at 298.31%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-10160.00%
Negative EPS growth while OBE is at 316.67%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-10160.00%
Negative diluted EPS growth while OBE is at 316.67%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.27%
OCF growth under 50% of OBE's 19.66%. Michael Burry might suspect questionable revenue recognition or rising costs.
67.00%
FCF growth 75-90% of OBE's 88.50%. Bill Ackman might push for improved capital allocation or operational changes to match the competitor.
-48.13%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-85.70%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-80.18%
Negative 3Y CAGR while OBE stands at 103.99%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
73.40%
OCF/share CAGR of 73.40% while OBE is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
-68.02%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-67.08%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-716.99%
Negative 10Y net income/share CAGR while OBE is at 34.45%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-212.50%
Negative 5Y net income/share CAGR while OBE is 163.94%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-732.46%
Negative 3Y CAGR while OBE is 596.68%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
0.18%
Below 50% of OBE's 57.79%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-59.22%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-71.24%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
397.82%
Dividend/share CAGR of 397.82% while OBE is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
7.00%
Stable or rising mid-term dividends while OBE is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
-50.19%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
0.50%
Our AR growth while OBE is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
No Data
No Data available this quarter, please select a different quarter.
-13.56%
Negative asset growth while OBE invests at 0.37%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-19.31%
We have a declining book value while OBE shows 1.23%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-0.20%
We’re deleveraging while OBE stands at 8.65%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-6.86%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.